Balance Sheet Breakdown: Charles River Laboratories International Inc (CRL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

After finishing at $173.88 in the prior trading day, Charles River Laboratories International Inc (NYSE: CRL) closed at $165.35, down -4.91%. In other words, the price has decreased by -$4.91 from its previous closing price. On the day, 1.54 million shares were traded.

Ratios:

Our goal is to gain a better understanding of CRL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 41.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.79.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on March 04, 2025, Upgraded its rating to Neutral and sets its target price to $175 from $155 previously.

On March 03, 2025, Redburn Atlantic Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $188.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 ’25 when FOSTER JAMES C bought 6,075 shares for $165.01 per share. The transaction valued at 1,002,436 led to the insider holds 183,639 shares of the business.

Girshick Birgit bought 1,514 shares of CRL for $249,250 on Feb 20 ’25. The Corporate Executive VP & COO now owns 55,058 shares after completing the transaction at $164.63 per share. On Feb 20 ’25, another insider, LaPlume Joseph W, who serves as the EVP, Corp Strategy & Develop of the company, sold 4,400 shares for $162.50 each. As a result, the insider received 715,000 and left with 20,013 shares of the company.

Valuation Measures:

As of this moment, Charles’s Price-to-Earnings (P/E) ratio for their current fiscal year is 644.64, and their Forward P/E ratio for the next fiscal year is 16.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 183.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.09 while its Price-to-Book (P/B) ratio in mrq is 2.44.

Stock Price History:

Over the past 52 weeks, CRL has reached a high of $274.77, while it has fallen to a 52-week low of $150.79. The 50-Day Moving Average of the stock is -1.38%, while the 200-Day Moving Average is calculated to be -14.28%.

Shares Statistics:

A total of 51.14M shares are outstanding, with a floating share count of 50.57M. Insiders hold about 1.12% of the company’s shares, while institutions hold 105.01% stake in the company.

Most Popular